PET diagnostic imaging

PROCEDURE2 trials

Sponsors

Ontario Clinical Oncology Group (OCOG)

Conditions

Colorectal CancerLiver MetastasesNon-Small-Cell Lung Carcinoma

Phase 3

Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)

CompletedNCT00136864

Ontario Clinical Oncology Group (OCOG)Non-Small-Cell Lung Carcinoma

Start: 2004-08-31End: 2011-09-30Updated: 2011-11-18

Impact of Positron Emission Tomography Imaging Prior to Liver Resection for Colorectal Adenocarcinoma Metastases

CompletedNCT00265356

Ontario Clinical Oncology Group (OCOG)Colorectal Cancer, Liver Metastases

Start: 2005-11-30End: 2013-04-30Updated: 2013-10-21

Related Papers

Effect of PET-CT on disease recurrence and its management in patients with potentially resectable colorectal cancer liver metastases. The long-term results of a randomized controlled trial (PET-CT Imaging prior to liver resection for colorectal adenocarcinoma metastases).

Journal of Clinical Oncology2018-05-202 citations

Effect of PET Before Liver Resection on Surgical Management for Colorectal Adenocarcinoma Metastases

JAMA2014-05-13168 citations